FCM Investments’s AbbVie ABBV Stock Holding History

FCM Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,500	Closed	-$489K	–	49
2017 Q1	$489K	Hold	7,500	–	–	0.31%	45
2016 Q4	$470K	Sell	7,500 -450	-6%	-$27.5K	0.28%	50
2016 Q3	$501K	Hold	7,950	–	–	0.28%	50
2016 Q2	$492K	Hold	7,950	–	–	0.29%	46
2016 Q1	$454K	Hold	7,950	–	–	0.24%	48
2015 Q4	$471K	Hold	7,950	–	–	0.24%	52
2015 Q3	$433K	Hold	7,950	–	–	0.21%	50
2015 Q2	$534K	Hold	7,950	–	–	0.25%	49
2015 Q1	$465K	Hold	7,950	–	–	0.22%	51
2014 Q4	$520K	Hold	7,950	–	–	0.24%	51
2014 Q3	$459K	Hold	7,950	–	–	0.21%	49
2014 Q2	$449K	Hold	7,950	–	–	0.21%	53
2014 Q1	$409K	Hold	7,950	–	–	0.17%	53
2013 Q4	$420K	Sell	7,950 -500	-6%	-$24.6K	0.17%	55
2013 Q3	$378K	Sell	8,450 -667	-7%	-$29.6K	0.15%	56
2013 Q2	$377K	Buy	+9,117	New	+$399K	0.17%	59

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FCM Investments's ABBV Position: Q2 2017 in Review

FCM Investments sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 7,500 shares — an estimated $489K sold.

FCM Investments first reported a position in ABBV in Q2 2013 and held it in 16 quarters. The position peaked at $534K in Q2 2015. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

FCM Investments reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
FCM Investments sold 7,500 AbbVie shares in Q2 2017, an estimated $489K.
FCM Investments first reported a position in AbbVie in Q2 2013 and held it in 16 quarters.
FCM Investments's AbbVie position peaked at $534K in Q2 2015.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.